Travere Therapeutics Inc (TVTX)
R&D to Revenue
35.55%
Quarterly · Period ending:
TVTX R&D to Revenue
Latest reported35.55%period ending
Latest reported35.55%period ending
TVTX Quarterly R&D/Revenue (0.00% → 35.55%)
Latest values, visible window
High-resolution chart · PNG
TVTX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 35.5476% | |
| 44.8856% | |
| 44.6221% | |
| 31.4754% | |
| 43.1301% | |
| 57.3692% | |
| 82.9917% | |
| 82.1632% | |
| 100.3954% | |
| 277.046% | |
| 130.3824% | |
| 163.3374% | |
| 206.5225% | |
| 105.1234% | |
| 107.8113% | |
| 203.5441% | |
| 110.1796% | |
| 116.755% | |
| 108.5923% | |
| 70.9603% | |
| 94.8551% | |
| 101.137% | |
| 75.2918% | |
| 63.257% | |
| 63.5763% | |
| 63.3235% | |
| 77.2661% | |
| 74.8653% | |
| 84.8502% | |
| 84.516% | |
| 73.0963% | |
| 79.7131% | |
| 83.3636% | |
| 64.1028% | |
| 46.4139% | |
| 48.6118% | |
| 50.2113% | |
| 62.0464% | |
| 53.7909% | |
| 54.2878% | |
| 53.0606% | |
| 50.5792% | |
| 50.7505% | |
| 50.2196% | |
| 43.8882% | |
| 59.5589% | |
| 100.7582% | |
| 155.9394% | |
| 238.5689% | |
| 24,683.6057% | |
| 2,485.098% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |